Mr. Kyle Kingsley reports

GOODNESS GROWTH HOLDINGS LAUNCHES CANNABIS-INFUSED GUMMIES IN MINNESOTA

Goodness Growth Holdings Inc. has added cannabis-infused gummies to its Vireo brand in Minnesota in accordance with Minnesota's new regulations, effective Aug. 1, allowing certified medical cannabis patients in the state to purchase certain edible products containing cannabis.

The addition of edibles, including gummies with cannabis, into Minnesota's medical cannabis program offers an additional and sought-after delivery method for patients.

"Minnesota's medical cannabis program allows for people with a variety of different medical diagnoses to seek relief using medical cannabis," said Kyle Kingsley, MD, Goodness Growth chairman and chief executive officer. "The more options we are able to offer our patients, the better we are able to meet their different medical needs, and patients can rest assured that our gummies, like all of our products, are tested by licensed, independent quality assurance laboratories to ensure they meet strict standards for purity, potency and quality."

Vireo's gummies are designed to meet the needs of a variety of cannabis patients. At launch, the gummies are available in 10-milligram tetrahydrocannabinol formulations and in key lime, concord grape, Hawaiian pineapple and Oxnard strawberry flavours. An additional formulation, with equal amounts of tetrahydrocannabinol and cannabidiol and in Alfonso mango flavour, is expected to follow. Vireo gummies are available in all eight of the company's Green Goods dispensaries in Minnesota.

About Goodness Growth Holdings Inc.

Goodness Growth is a physician-led, science-focused holding company whose mission is to bring the power of plants to the world. The company's operations consist primarily of its multistate cannabis company subsidiary, Vireo Health Inc., and its science and intellectual property incubator, Resurgent Biosciences Inc. The company manufactures proprietary, branded cannabis products in environmentally friendly facilities and state-of-the-art cultivation sites and distributes its products through its growing network of Green Goods and other retail locations and third party dispensaries. Its team of more than 500 employees is focused on the development of differentiated products, driving scientific innovation of plant-based medicines and developing meaningful intellectual property. Today, the company is licensed to grow, process and/or distribute cannabis in five markets, and operates 18 dispensaries across the United States.